<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Aptos;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:10.0pt;
font-family:"Aptos",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Aptos",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;
mso-ligatures:none;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1959870862;
mso-list-template-ids:984275154;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt">Hello Aleena,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">The Ensembl Perl API at <a href="ftp://ftp.ensembl.org/pub/ensembl-api.tar.gz">
ftp://ftp.ensembl.org/pub/ensembl-api.tar.gz</a> remains at version 113. Will this be updated?<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Thank you,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Eric<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<br>
<p style="font-family:Calibri;font-size:12pt;color:#898989;margin:5pt;font-style:normal;font-weight:normal;text-decoration:none;" align="Center">
Regeneron - Internal<br>
</p>
<br><p style='font-family:Calibri;font-size:12pt;color:#898989;margin:5pt;font-style:normal;font-weight:normal;text-decoration:none;' align='Center'>Regeneron - Internal<br></p>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif">From:</span></b><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"> Dev <dev-bounces@ensembl.org>
<b>On Behalf Of </b>Aleena<br>
<b>Sent:</b> Wednesday, May 7, 2025 11:39 AM<br>
<b>To:</b> dev@ensembl.org<br>
<b>Subject:</b> [External] [ensembl-dev] Ensembl release 114 is now out!<o:p></o:p></span></p>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<p class="MsoNormal" style="mso-line-height-alt:.75pt"><span style="font-size:1.0pt;color:white">Hi, We are pleased to announce that the latest Ensembl 114 and corresponding Ensembl Genomes 61 updates have been released! Highlights of this release include:
The GENCODE Primary tag is now the default gene display in human and mouse<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="mso-line-height-alt:.75pt"><span style="font-size:1.0pt;color:white"><o:p></o:p></span></p>
</div>
<div name="messageBodySection">
<div>
<p class="MsoNormal"><span style="font-size:12.0pt">Hi,<br>
<br>
We are pleased to announce that the latest Ensembl 114 and corresponding Ensembl Genomes 61 updates have been released!<br>
Highlights of this release include:<o:p></o:p></span></p>
</div>
<ul type="disc">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1">
<span style="font-size:12.0pt">The <a href="https://urldefense.com/v3/__https:/www.gencodegenes.org/__;!!ODpDvJZr5w!AH8lvCVl-3pSP4-jD8r0jwbGmBzNvTZUqxKBtt2csEQUhhZFJldcHtV3N8IDKdqQbIkfqR-F-hvY00GuG4xtDn8D$" target="_blank">GENCODE</a> Primary tag is now the
default gene display in human and mouse<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1">
<span style="font-size:12.0pt"><a href="https://urldefense.com/v3/__https:/www.ensembl.org/info/genome/genebuild/mane.html__;!!ODpDvJZr5w!AH8lvCVl-3pSP4-jD8r0jwbGmBzNvTZUqxKBtt2csEQUhhZFJldcHtV3N8IDKdqQbIkfqR-F-hvY00GuGz2NcPgP$" target="_blank">MANE</a> has
been updated to release v1.4<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1">
<span style="font-size:12.0pt">Rat reference genome updated from mRatBN7.2 to GRCr8<o:p></o:p></span></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1">
<span style="font-size:12.0pt">New variation data from<a href="https://urldefense.com/v3/__https:/www.ebi.ac.uk/eva/__;!!ODpDvJZr5w!AH8lvCVl-3pSP4-jD8r0jwbGmBzNvTZUqxKBtt2csEQUhhZFJldcHtV3N8IDKdqQbIkfqR-F-hvY00GuGzbyu7ud$" target="_blank"> EVA </a>release 6
is available for many species<o:p></o:p></span></li></ul>
<div>
<p class="MsoNormal"><span style="font-size:12.0pt"><br>
The release blog post with all news can be viewed here (<a href="https://urldefense.com/v3/__https:/www.ensembl.info/2025/05/07/ensembl-114-has-been-released/__;!!ODpDvJZr5w!AH8lvCVl-3pSP4-jD8r0jwbGmBzNvTZUqxKBtt2csEQUhhZFJldcHtV3N8IDKdqQbIkfqR-F-hvY00GuGztbFxqV$" target="_blank">https://www.ensembl.info/2025/05/07/ensembl-114-has-been-released/</a>).<br>
<br>
For the latest news from the Ensembl project visit our blog. Thank you all!<br>
<br>
All the best (on behalf of the Ensembl team)<o:p></o:p></span></p>
</div>
</div>
<div name="messageSignatureSection">
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal"><span style="font-size:12.0pt">Best wishes, <o:p></o:p></span></p>
<div>
<p class="MsoNormal"><span style="font-size:12.0pt">Aleena Mushtaq Stolworthy (She/her)<o:p></o:p></span></p>
</div>
<p class="MsoNormal" style="margin-bottom:12.0pt"><span style="font-size:12.0pt">Ensembl Outreach Officer<o:p></o:p></span></p>
<div>
<p class="MsoNormal"><span style="font-size:12.0pt">European Bioinformatics Institute (EMBL-EBI)<br>
European Molecular Biology Laboratory<br>
Wellcome Trust Genome Campus<br>
Hinxton<br>
Cambridge<br>
CB10 1SD<br>
UK<o:p></o:p></span></p>
</div>
</div>
</div>
</div>
<DIV>
******************************************************************** <BR>
This e-mail and any attachment hereto, is intended only for use by the addressee(s) named above and may contain legally privileged and/or confidential information. If you are not the intended recipient of this e-mail, any dissemination, distribution or copying of this email, or any attachment hereto, is strictly prohibited. If you receive this email in error please immediately notify me by return electronic mail and permanently delete this email and any attachment hereto, any copy of this e-mail and of any such attachment, and any printout thereof. Finally, please note that only authorized representatives of Regeneron Pharmaceuticals, Inc. have the power and authority to enter into business dealings with any third party. <BR>
********************************************************************<BR>
</DIV></body>
</html>